Roth Capital Downgraded RTI Biologics, Inc. to Neutral, Raised PT to $5.00
Tickers: RTIX
Get News First. Profit Faster
With Benzinga Professional get unlimited access to ALL content! PLUS:
- REALTIME NEWSFEED
- REALTIME AUDIO NEWS
- FULL CALENDAR SUITE
- CHAT WITH OUR NEWS DESK
RECENT PRO ALERTS
Sonic Sees Systemwide Comps Up 0.1% in Q3, Sees Double-Digit Earnings Growth Over Next Several Years
08:38am - June 11, 2013EU's Rehn Says Premature to Discuss Further Debt Relief for Greece, Greece Should Focus on Current Program - MNI
08:37am - June 11, 2013Cerus Starts Patient Enrollment for European Phase III Trial for INTERCEPT
08:36am - June 11, 2013
Posted in: News, Downgrades, Analyst Ratings